Kai-Jin Xu Selected Research

Pneumonia (Pneumonitis)

12/2020

Safety of protease inhibitors and Arbidol for SARS-CoV-2 pneumonia in Zhejiang Province, China.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kai-Jin Xu Research Topics

Disease

2	Hepatitis B 01/2018 - 02/2016
2	Infections 01/2015 - 11/2006
1	Pneumonia (Pneumonitis) 12/2020
1	Osteomyelitis 01/2015
1	Chronic Hepatitis B 10/2014
1	Hyperbilirubinemia 11/2006
1	Bacterial Infections (Bacterial Infection) 11/2006
1	Fibrosis (Cirrhosis) 11/2006
1	Endotoxemia 04/2006
1	Reperfusion Injury 05/2005
1	Ischemia 05/2005

Drug/Important Bio-Agent (IBA)

2	Antiviral Agents (Antivirals)IBA 12/2020 - 10/2014
1	umifenovirIBA 12/2020
1	Protease Inhibitors (Protease Inhibitor)IBA 12/2020
1	AntibodiesIBA 01/2018
1	Hepatitis B Vaccines (Hepatitis B Vaccine)IBA 02/2016
1	Pharmaceutical PreparationsIBA 01/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2015
1	Malondialdehyde (Propanedial)IBA 04/2006
1	EnzymesIBA 04/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2006
1	Alanine Transaminase (SGPT)IBA 04/2006
1	Gentamicins (Gentamicin)FDA LinkGeneric 04/2006
1	Superoxide DismutaseIBA 04/2006
1	salicylhydroxamic acid (SHAM)IBA 05/2005
1	EndotoxinsIBA 05/2005

Therapy/Procedure

2	Therapeutics 01/2015 - 10/2014
1	Drug Therapy (Chemotherapy) 01/2015
1	Debridement 01/2015
1	Liver Transplantation 11/2006